Literature DB >> 15916619

The placebo response in functional bowel disorders: perspectives and putative mechanisms.

P Enck1, S Klosterhalfen.   

Abstract

The nature and determinants of the placebo response are widely unknown, as are the underlying psychological and biological mechanisms. High placebo response rates in functional bowel disorders (functional dyspepsia, irritable bowel syndrome) are similar to those in non-intestinal diseases (depression, pain, Parkinson's disease) and not too dissimilar to other organic gastrointestinal diseases (duodenal ulcer, inflammatory bowel diseases). Methodological reasons (regression to the mean, shift in signal detection through manipulation of expectations) and psycho-biological mechanisms (Pavlovian conditioning of biological processes) are proposed to explain a large component of the response variance in clinical trials. Psychobiological mechanisms of the placebo response in functional and organic diseases can also be identified in brain function studies (such as imaging).

Entities:  

Mesh:

Year:  2005        PMID: 15916619     DOI: 10.1111/j.1365-2982.2005.00676.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  24 in total

1.  Acupuncture treatment in irritable bowel syndrome.

Authors:  A Schneider; P Enck; K Streitberger; C Weiland; S Bagheri; S Witte; H-C Friederich; W Herzog; S Zipfel
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

2.  Self-help interventions in irritable bowel syndrome.

Authors:  A P S Hungin
Journal:  Gut       Date:  2006-05       Impact factor: 23.059

Review 3.  The psyche and the gut.

Authors:  Paul Enck; Ute Martens; Sibylle Klosterhalfen
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

Review 4.  Developmental influences on medically unexplained symptoms.

Authors:  C A Tony Buffington
Journal:  Psychother Psychosom       Date:  2009-03-09       Impact factor: 17.659

5.  Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation.

Authors:  Sarah Ballou; Alissa Beath; Ted J Kaptchuk; William Hirsch; Thomas Sommers; Judy Nee; Johanna Iturrino; Vikram Rangan; Prashant Singh; Mike Jones; Anthony Lembo
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-12       Impact factor: 11.382

6.  Systematic Review: FDA-Approved Prescription Medications for Adults With Constipation.

Authors:  Brooks D Cash; Brian E Lacy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-10

7.  Probiotic treatment of irritable bowel syndrome in children.

Authors:  U Martens; P Enck; E Zieseniss
Journal:  Ger Med Sci       Date:  2010-03-02

Review 8.  Placebo responses in patients with gastrointestinal disorders.

Authors:  Frauke Musial; Sibylle Klosterhalfen; Paul Enck
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

9.  The Effects of Banha-sasim-tang on Dyspeptic Symptoms and Gastric Motility in Cases of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled, and Two-Center Trial.

Authors:  Jae-Woo Park; Seok-Jae Ko; Gajin Han; Inkwon Yeo; Bongha Ryu; Jinsung Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-03       Impact factor: 2.629

Review 10.  Guidelines on the irritable bowel syndrome: mechanisms and practical management.

Authors:  R Spiller; Q Aziz; F Creed; A Emmanuel; L Houghton; P Hungin; R Jones; D Kumar; G Rubin; N Trudgill; P Whorwell
Journal:  Gut       Date:  2007-05-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.